BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients

Update Il y a 4 ans
Reference: NCT01624493

Woman Man

Extract

This phase I/II trial will determine the recommended dose and activity of BNC105P for patients with partially platinum sensitive ovarian cancer in first or second relapse.


Inclusion criteria

  • Ovarian Cancer

Links